Latest News and Press Releases
Want to stay updated on the latest news?
-
Vancouver, B.C., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE: ORIG) (the “Company” or “Origin Therapeutics”), an actively managed, psychedelics industry-focused...
-
Vancouver, B.C., July 07, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE:ORIG) (the “Company” or “Origin Therapeutics”), an actively managed, psychedelics industry-focused...
-
Vancouver, B.C., June 14, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE:ORIG) (the “Company” or “Origin Therapeutics”), an actively managed, psychedelics industry-focused...
-
Vancouver, B.C., June 14, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE:ORIG) (the “Company” or “Origin Therapeutics”), an actively managed, psychedelics industry-focused...
-
Vancouver, B.C., June 02, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”), an actively managed, psychedelics industry-focused investment issuer,...
-
Vancouver, B.C. & Toronto, ON, May 17, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”), an actively managed, psychedelics industry-focused...
-
Vancouver, B.C. & Toronto, ON, March 29, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”), an actively managed, psychedelic-focused investment...
-
Vancouver, British Columbia, March 23, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”), an actively managed, psychedelic-focused investment...
-
Vancouver, British Columbia, Jan. 27, 2022 (GLOBE NEWSWIRE) -- January 27, 2022 – Origin Therapeutics Holdings Inc. (CSE: ORIG Proposed) (the “Company” or “Origin Therapeutics”) an actively managed...
-
Vancouver, British Columbia, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (CSE: ORIG Proposed) (the “Company” or “Origin Therapeutics”), an actively managed,...